Literature DB >> 10617020

Tissue engineering of autologous aorta using a new biodegradable polymer.

D Shum-Tim1, U Stock, J Hrkach, T Shinoka, J Lien, M A Moses, A Stamp, G Taylor, A M Moran, W Landis, R Langer, J P Vacanti, J E Mayer.   

Abstract

BACKGROUND: Ovine pulmonary valve leaflets and pulmonary arteries have been tissue-engineered (TE) from autologous cells and biodegradable polyglycolic acid (PGA)-polyglactin copolymers. Use of this cell-polymer construct in the systemic circulation resulted in aneurysm formation. This study evaluates a TE vascular graft in the systemic circulation which is based on a new copolymer of PGA and polyhydroxyalkanoate (PHA).
METHODS: Ovine carotid arteries were harvested, expanded in vitro, and seeded onto 7-mm diameter PHA-PGA tubular scaffolds. The autologous cell-polymer vascular constructs were used to replace 3-4 cm abdominal aortic segments in lambs (group TE, n = 7). In a control group (n = 4), aortic segments were replaced with acellular polymer tubes. Vascular patency was evaluated with echography. All control animals were sacrificed when the grafts became occluded. Animals in TE group were sacrificed at 10 days (n = 1), 3 (n = 3), and 5 months (n = 3). Explanted TE conduits were evaluated for collagen content, deoxyribonucleic acid (DNA) content, structural and ultrastructural examination, mechanical strength, and matrix metalloproteinase (MMP) activity.
RESULTS: The 4 control conduits became occluded at 1, 2, 55, and 101 days. All TE grafts remained patent, and no aneurysms developed by the time of sacrifice. There was one mild stenosis at the anastomotic site after 5 months postoperatively. The percent collagen and DNA contents approached the native aorta over time (% collagen = 25.7%+/-3.4 [3 months] vs 99.6%+/-11.7 [5 months], p < 0.05; and % DNA = 30.8%+/-6.0 [3 months] vs 150.5%+/-16.9 [5 months], p < 0.05). Histology demonstrated elastic fibers in the medial layer and endothelial specific von Willebrand factor on the luminal surface. The mechanical strain-stress curve of the TE aorta approached that of the native vessel. A 66 kDa MMP-2 was found in the TE and native aorta but not in control group.
CONCLUSIONS: Autologous aortic grafts with biological characteristics resembling the native aorta can be created using TE approach. This may allow the development of "live" vascular grafts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10617020     DOI: 10.1016/s0003-4975(99)01055-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  42 in total

Review 1.  Heart valve and arterial tissue engineering.

Authors:  C E Sarraf; A B Harris; A D McCulloch; M Eastwood
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

2.  Tissue morphogenesis under the conditions of implantation of polyhydroxybutyrate, a biodegradable polymer.

Authors:  E I Shishatskaya; T G Volova; A P Puzyr; O A Mogil'naya; S N Efremov; I I Gitelson
Journal:  Dokl Biol Sci       Date:  2002 Mar-Apr

Review 3.  Genetic modification of xenografts.

Authors:  J L Platt
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

Review 4.  Designer blood vessels and therapeutic revascularization.

Authors:  Joseph D Berglund; Zorina S Galis
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 5.  Engineering of bypass conduits to improve patency.

Authors:  S T Rashid; H J Salacinski; B J Fuller; G Hamilton; A M Seifalian
Journal:  Cell Prolif       Date:  2004-10       Impact factor: 6.831

Review 6.  Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly.

Authors:  Chris A Bashur; Lavanya Venkataraman; Anand Ramamurthi
Journal:  Tissue Eng Part B Rev       Date:  2012-03-02       Impact factor: 6.389

Review 7.  Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.

Authors:  Jeffrey A Beamish; Ping He; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

Review 8.  Getting to the heart of tissue engineering.

Authors:  Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

Review 9.  Cardiovascular Tissue Engineering: Preclinical Validation to Bedside Application.

Authors:  Cameron Best; Ekene Onwuka; Victoria Pepper; Malik Sams; Jake Breuer; Christopher Breuer
Journal:  Physiology (Bethesda)       Date:  2016-01

Review 10.  Biomaterials for vascular tissue engineering.

Authors:  Swathi Ravi; Elliot L Chaikof
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.